Document Type : Clinical Notes


Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran




  1. Lee SJ. Classification systems for chronic graft-versus-host disease. Blood 2017; 129(1): 30-7.
  2. Hildebrandt GC, Fazekas T, Lawitschka A, Bertz H, Greinix H, Halter J, et al. Diagnosis and treatment of pulmonary chronic GVHD: Report from the consensus conference on clinical practice in chronic GVHD. Bone Marrow Transplant 2011; 46(10): 1283-95.
  3. Ahmed Z, Schoen M, Rajeh N. Myasthenia gravis presenting as graft versus host disease after allogeneic blood stem cell transplant. Case Rep Hematol 2018; 2018: 7296930.
  4. Tsutsumi Y, Kamiishi T, Kikuchi R, Ito S, Matsuoka S, Teshima T. Myasthenia gravis after allogeneic bone marrow transplantation: A case report and literature review. Hematol Oncol Stem Cell Ther 2019; 12(2): 110-4.
  5. Alousi AM, Uberti J, Ratanatharathorn V. The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant. Leuk Lymphoma 2010; 51(3): 376-89.